Vinva Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.6M Buy
173,440
+17,781
+11% +$2.49M 0.29% 91
2025
Q4
$19.2M Buy
155,659
+54,664
+54% +$6.64M 0.24% 107
2025
Q3
$11.4M Buy
100,995
+14,109
+16% +$1.6M 0.22% 117
2025
Q2
$9.62M Buy
86,886
+8,713
+11% +$927K 0.25% 103
2025
Q1
$8.74M Sell
78,173
-6,380
-8% -$658K 0.35% 66
2024
Q4
$7.78M Sell
84,553
-8,691
-9% -$783K 0.3% 75
2024
Q3
$7.8M Sell
93,244
-33,668
-27% -$2.57M 0.33% 75
2024
Q2
$8.74M Buy
126,912
+32,468
+34% +$2.17M 0.44% 49
2024
Q1
$6.92M Sell
94,444
-22,889
-20% -$1.76M 0.39% 56
2023
Q4
$9.52M Buy
117,333
+32,681
+39% +$2.54M 0.65% 27
2023
Q3
$6.38M Buy
84,652
+40,652
+92% +$3.13M 0.6% 36
2023
Q2
$3.34M Buy
44,000
+1,102
+3% +$87.9K 0.29% 84
2023
Q1
$3.49M Buy
+42,898
New +$3.55M 0.29% 91

Other funds holding GILD

Vinva Investment Management's GILD Position: Q1 2026 in Review

Vinva Investment Management increased its Gilead Sciences (GILD) stake by 11% in Q1 2026, buying an estimated $2.49M and bringing the position to 173,440 shares worth $23.6M. The position accounts for 0.29% of the portfolio, ranked #91.

Vinva Investment Management first reported a position in GILD in Q1 2023 and has held it in 13 quarters since. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Vinva Investment Management held 173,440 shares of Gilead Sciences worth $23.6M as of Q1 2026.
  • Vinva Investment Management bought 17,781 Gilead Sciences shares in Q1 2026, an estimated $2.49M.
  • Gilead Sciences made up 0.29% of Vinva Investment Management's portfolio in Q1 2026, its #91 holding.
  • Vinva Investment Management first reported a position in Gilead Sciences in Q1 2023 and has held it in 13 quarters since.
  • 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.